AZM 475271
Tocris Bioscience, part of Bio-Techne | Catalog # 3963
Src tyrosine kinase inhibitor
Key Product Details
Description
Src tyrosine kinase inhibitor
Product Description
AZM 475271 is a src tyrosine kinase inhibitor. Reduces tumor size, vascularity and metastasis, and increases apoptosis in human pancreatic cells grown in nude mice. Also exhibits antiangiogenic activity in vitro and in vivo. Sensitizes tumor cells to the cytotoxic effects of gemcitabine (Cat. No. 3259).Licensing Information
Sold with the permission of AstraZeneca UK Ltd.Product Specifications
Molecular Weight
442.94
Formula
C23H27ClN4O3
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
N-(2-Chloro-5-methoxyphenyl)-6-methoxy
CAS Number
476159-98-5
PubChem ID
5330175
InChI Key
WPOXAFXHRJYEIC-UHFFFAOYSA-N
SMILES
ClC1=CC=C(OC)C=C1NC3=NC=NC2=CC(OCC4CCN(C)CC4)=C(OC)C=C23
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 44.29 | 100 |
Preparing Stock Solutions
for AZM 475271
The following data is based on the product molecular weight 442.94
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.26 mL | 11.29 mL | 22.58 mL |
| 5 mM | 0.45 mL | 2.26 mL | 4.52 mL |
| 10 mM | 0.23 mL | 1.13 mL | 2.26 mL |
| 50 mM | 0.05 mL | 0.23 mL | 0.45 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Summy AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes. Mol.Cancer Ther. 2005 PMID: 16373705
- Yezhelyev Inhibition of Src tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin.Cancer Res. 2004 PMID: 15585638
Product Specific Notices for AZM 475271
For research use only
Loading...
Loading...